TRANSGENOMIC

Transgenomic, Inc. (Transgenomic) provides products for the purification and analysis of nucleic acids used in the life sciences industry for research focused on molecular genetics and diagnostics. The Company also provides genetic variation analytical services to the medical research, clinical and pharmaceutical markets. Its products and services are categorized as Instrument Related Business and Laboratory Services. It has sold its products to customers in over 50 countries. Customers incl... ude numerous academic and medical institutions in the United States and abroad. In addition, its customers also include number of pharmaceutical, biotech and commercial companies both in the United States and abroad. In December 2010, the Company acquired Clinical Data, Inc.'s diagnostic business. ransgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products, including its flagship C-GAAP test, designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.
TRANSGENOMIC
Industry:
Biotechnology Genetics Health Care Health Diagnostics Life Science
Founded:
1997-01-01
Address:
Omaha, Nebraska, United States
Country:
United States
Website Url:
http://www.transgenomic.com
Total Employee:
101+
Status:
Active
Contact:
4024525461
Email Addresses:
[email protected]
Total Funding:
18.64 M USD
Technology used in webpage:
Amazon Amazon Frankfurt Region Submittable
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Crede CapitalGroup
Crede CapitalGroup investment in Post-IPO Equity - Transgenomic
Crede CapitalGroup
Crede CapitalGroup investment in Post-IPO Equity - Transgenomic
Third Security
Third Security investment in Post-IPO Equity - Transgenomic
Official Site Inspections
http://www.transgenomic.com Semrush global rank: 13.27 M Semrush visits lastest month: 78
- Host name: ns2.namepros-dns.com
- IP address: 3.233.30.191
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Transgenomic"
Transgenomic - LinkedIn
Transgenomic | 1,351 followers on LinkedIn. Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited ...See details»
Transgenomic Inc. - SelectScience
Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary โฆSee details»
Transgenomic Company Profile | Management and Employees List โฆ
Transgenomic Profile and History Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through โฆSee details»
Transgenomic 2025 Company Profile: Valuation, โฆ
Transgenomic General Information Description. Precipio Inc is a diagnostics company, which has built a platform designed to eradicate the problem of โฆSee details»
Transgenomic - Contacts, Employees, Board Members, Advisors
Organization. Transgenomic . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Transgenomic has 1 current employee profile, Vice President โฆSee details»
www.transgenomic.com
Www.transgenomic.comSee details»
Transgenomic: Revenue, Worth, Valuation & Competitors 2024
About Transgenomic. Transgenomic is a Biotech related company founded in 1997 and based in Lexington with an estimated revenue of $3.5M, and 43 employees. It has 10 competitors โฆSee details»
Transgenomic - Funding, Financials, Valuation & Investors
Transgenomic offers products for purification and analysis of nucleic acids used in the life sciences industry for research. New. Resources. Advanced Search. ... How much funding has โฆSee details»
TRANSGENOMIC Company Profile | Omaha, NE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TRANSGENOMIC of Omaha, NE. Get the latest business insights from Dun & Bradstreet.See details»
Transgenomic - M&A Summary and Business Overview | Mergr
Transgenomic disclosed revenue of 27M USD for 2014 and 27M USD for 2013. How many employees does Transgenomic have? Transgenomic has 150 employees. What sector is โฆSee details»
Precipio Diagnostics and Transgenomic Complete Merger
Jun 30, 2017 Transgenomic (TBIOD) completes merger and changes name to Precipio (PRPO); relists on NASDAQ, ... Post-merger, management anticipates the new organization will be a โฆSee details»
Transgenomic - Products, Competitors, Financials, Employees ...
Transgenomic is a global biotechnology company focused on advancing personalized medicine in the fields of cardiology, oncology, and inherited diseases. The company offers molecular โฆSee details»
Transgenomic | Nebraska Business Development Center
Transgenomic has an exclusive license for the method. Transgenomicโs main focus is currently on developing research products for pharmaceutical clients working on cancer drugs, patient โฆSee details»
Transgenomic Company Overview, Contact Details & Competitors โฆ
Apr 17, 2017 precipio partnered with transgenomic on Jan 1st '17. Moreover, Precipio, a U.S.-based organization, entered into a merger agreement with Transgenomic in 2017, for โฆSee details»
Transgenomic - Company Profile - Tracxn
Feb 19, 2025 Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, โฆSee details»
Transgenomic - Overview, News & Similar companies - ZoomInfo
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through advance d diagnostic technologies, such โฆSee details»
Transgenomic | New Haven CT - Facebook
Transgenomic, New Haven, Connecticut. 264 likes · 6 were here. Leaders in the translation of molecular genetics into clinical practice.See details»
Transgenomic, Inc. : Transgenomic and ScreenCell Announce โฆ
Nov 8, 2011 Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cancer and inherited diseases through its proprietary โฆSee details»
Tri-omic single-cell mapping of the 3D epigenome and ... - Nature
1 day ago This work introduces ChAIR, a droplet-based tri-omic tool that enables the simultaneous profiling of the transcriptome, chromatin accessibility and chromatin โฆSee details»
Transgenomic - Updates, News, Events, Signals & Triggers
Transgenomic may be growing as it is listed among other key players in the genetic disease diagnostic market, which suggests that it holds a significant position in the industry. The โฆSee details»